Evergreen Theragnostics logo

Evergreen Theragnostics Funding & Investors

Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s unmatched expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regul... Read more

evergreentgn.com

Total Amount Raised: $60,000,000

Evergreen Theragnostics Funding Rounds

  • Series C

    $26,000,000

    Series C Investors

    LIFTT
    Petrichor Healthcare Capital Management
  • Series B

    $15,000,000

  • Series A

    $19,000,000

    Series A Investors

    Club degli Investitori
Funding info provided by Diffbot.